Legislature(2023 - 2024)BELTZ 105 (TSBldg)
02/20/2024 01:30 PM Senate COMMUNITY & REGIONAL AFFAIRS
Note: the audio
and video
recordings are distinct records and are obtained from different sources. As such there may be key differences between the two. The audio recordings are captured by our records offices as the official record of the meeting and will have more accurate timestamps. Use the icons to switch between them.
Audio | Topic |
---|---|
Start | |
SR3 | |
Presentation(s): Challenges in Rural Communities | |
Adjourn |
* first hearing in first committee of referral
+ teleconferenced
= bill was previously heard/scheduled
+ teleconferenced
= bill was previously heard/scheduled
*+ | SR 3 | TELECONFERENCED | |
+ | TELECONFERENCED |
SR 3-CHRONIC KIDNEY DISEASE AWARENESS MONTH 1:30:46 PM CHAIR DUNBAR announced the consideration of SENATE RESOLUTION NO. 3 Recognizing March 2024 as Chronic Kidney Disease Awareness Month in Alaska to raise awareness of the need for research, screening programs, and access to care for individuals who suffer from chronic kidney disease. He said that this is the introductory hearing of SR 3. The intention is to have committee discussion and hear public testimony. He invited Senator Gray-Jackson to put herself on record and introduce her resolution. 1:31:15 PM SENATOR GRAY-JACKSON, speaking as sponsor, introduced SR 3. She read the following sponsor statement: [Original punctuation provided.] The impact kidney disease has on patients and our healthcare system cannot be understated. To put it in perspective, there are more than 40 million people in the United States with kidney disease. This is roughly equivalent to the entire population of California. Even worse, more people will die from kidney disease this year than breast or prostate cancer. 1:32:16 PM Chronic kidney disease (CKD) is often asymptomatic in the beginning making early detection a challenge. Alaska has many high-risk populations. The high-risk ethnicities in Alaska include African Americans, Hispanics, Asian Americans, Pacific Islanders, and Alaska Natives and Native Americans. Another at-risk group includes individuals aged 65 and older, which make up nearly 14 percent of our population. Those living with kidney disease face challenges on many different fronts. Whether it is accessing a donor kidney for transplant, choosing between home or in- clinic dialysis while juggling a job or family responsibilities, or the constellation of challenges for this population adds an additional layer of stress to an already challenging chronic condition. A further complication for those suffering from chronic kidney disease is a lack of health insurance which results in lack of care and poorer health outcomes compared to 8 percent average nationwide. Nearly 13 percent of our population under the age of 65 are underinsured. Senate Resolution 3 seeks to reduce the impact of chronic kidney disease by increasing awareness and screening. 1:34:04 PM CHAIR DUNBAR invited questions from committee members. 1:34:13 PM SENATOR OLSON asked about the prevalence of chronic kidney disease and the number of people with kidney failure. SENATOR GRAY-JACKSON deferred the question to her staff, Ms. Odom. 1:34:28 PM BESSE ODOM, Staff, Senator Elvi Gray-Jackson, Alaska State Legislature, Juneau, Alaska, replied that the answer is a little hard to define. Kidney disease is not a medical issue that the state actively or aggressively tracks compared to other conditions, such as cancer, heart disease, or stroke. She said that she does not necessarily have those numbers, but there are over 600 Alaskans with chronic kidney disease who require dialysis treatment. SENATOR OLSON asked about the breakdown of that population, specifically the proportion of Alaska Natives and non-Alaska Natives. MS. ODOM replied that she does not have the breakdown but will gather that data for the committee. SENATOR OLSON asked whether the type of dialysis treatment is peritoneal dialysis, administered through the abdomen, or renal dialysis, administered through a shunt in the wrist or arm. MS. ODOM answered that the facility administers the treatment through a dialysis port. 1:36:08 PM CHAIR DUNBAR asked if there were further questions and found none. He opened public testimony on SR 3; finding none, he closed public testimony. CHAIR DUNBAR held SR 3 in committee. 1:36:56 PM SENATOR GRAY-JACKSON thanked the committee for hearing the resolution.
Document Name | Date/Time | Subjects |
---|---|---|
SR 3 Sponsor Statement.pdf |
SCRA 2/20/2024 1:30:00 PM |
SR 3 |
SR 3 ver A.pdf |
SCRA 2/20/2024 1:30:00 PM |
SR 3 |
AML - Challenges in Rural Communities.pptx |
SCRA 2/20/2024 1:30:00 PM |
|
SR3 Fresenius Medical Care Letter of Support_.pdf |
SCRA 2/20/2024 1:30:00 PM |
SR 3 |
AKPA Letter of Support for Senate Resolution No 3.pdf |
SCRA 2/20/2024 1:30:00 PM |
SR 3 |